Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

TAIGEN BIOSCIENCE CORP

Taigen Bioscience Corporation develops, manufactures, and sells nucleic acid extraction reagents, fully automated ins... read more Featured Products: More products

Download Mobile App




Commercial Molecular Assay Validated for Dengue Virus Outbreak

By LabMedica International staff writers
Posted on 28 Oct 2016
Dengue virus (DENV) is a member of the viral genus Flavivirus (family Flaviviridae) that is transmitted by mosquitos, causing endemic and epidemic outbreaks in tropical and subtropical areas.

Accurate, rapid, and early diagnosis of DENV infections is important for public health and optimal clinical care; however, the gold standard method of cell culture-dependent isolation of DENV during the acute phase of infection is time-consuming and cumbersome.

Medical scientists at the National Cheng Kung University (Tainan, Taiwan) collected serum samples from patients with suspected DENV infection between July and November 2015. Sera from patients with suspected DENV infection were screened using the one-step immunochromatographic SD BIOLINE Dengue DuoDengue NS1 Ag + Ab Combo assay. This rapid assay contains two test devices, which can simultaneously detect the levels of nonstructural protein 1(NS1) antigen, and immunoglobulin M (IgM) and IgG in a sample, respectively, within 15 minutes.

Viral ribonucleic acid (RNA) was extracted from serum samples and an extraction control sample using a QAIamp viral RNA mini kit or the automated extraction system LabTurbo Virus mini Kit in LabTurbo 48 Compact System. Quantitative real-time polymerase chain reaction (qRT-PCR) analysis of viral loads was performed using LightMix dengue virus EC kit, which is capable of identifying all four dengue serotypes.

A total of 8,989, 8,954, and 1,581 samples were subjected to NS1 antigen detection, IgM and IgG detection, and LightMix assays, respectively. The LightMix assay yielded a linear curve for viral loads (VL) between 102 and 106 copies/reaction, and the minimum detection limits for DENV serotype 1 (DENV1) and DENV2, DENV3, and DENV4 were 1, 10, and 100 focus forming units (FFU)/mL, respectively. There was 88.9% concordance between the results obtained using the NS1 antigen combo kit and by LightMix analysis, and the diagnostic sensitivity and specificity of the two methods were 89.4% and 100%, and 84.7% and 100%, respectively.

The authors concluded that the LightMix assay was effective for early diagnosis of DENV infection. The data indicated that high viral loads during primary infection in elderly patients may be a positive predictor for severe illness, and may contribute to high mortality rates. The study was published on October 12, 2016, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:
National Cheng Kung University



Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Respiratory Bacterial Panel
Real Respiratory Bacterial Panel 2
New
Multi-Function Pipetting Platform
apricot PP5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.